TC Biopharm (Holdings) Plc
TCBPY
$0.335
$0.026.35%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.65M | 2.70M | 1.41M | 2.72M | 1.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 7.60K | 7.70K | 47.40K | 3.00K | -92.70K |
| Total Operating Expenses | 4.66M | 4.74M | 2.64M | 4.37M | 3.93M |
| Operating Income | -4.66M | -4.74M | -2.64M | -4.37M | -3.93M |
| Income Before Tax | -4.66M | -4.74M | -2.64M | -4.35M | -4.13M |
| Income Tax Expenses | -278.80K | -283.30K | -133.40K | -140.40K | -241.40K |
| Earnings from Continuing Operations | -4.38M | -4.45M | -2.51M | -4.21M | -3.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.38M | -4.45M | -2.51M | -4.21M | -3.89M |
| EBIT | -4.66M | -4.74M | -2.64M | -4.37M | -3.93M |
| EBITDA | -4.54M | -4.62M | -2.49M | -4.21M | -3.75M |
| EPS Basic | -101.64K | -103.28K | -402.30K | -- | -- |
| Normalized Basic EPS | -16.89 | -17.16 | -66.21 | -- | -- |
| EPS Diluted | -103.36K | -105.03K | -402.30K | -- | -- |
| Normalized Diluted EPS | -16.89 | -17.16 | -66.21 | -- | -- |
| Average Basic Shares Outstanding | 172.50K | 172.50K | 24.90K | -- | -- |
| Average Diluted Shares Outstanding | 0.00 | 0.00 | 0.00 | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |